Malaria antigens and methods of use

    公开(公告)号:US10780153B2

    公开(公告)日:2020-09-22

    申请号:US16393035

    申请日:2019-04-24

    Applicant: GenVec, Inc.

    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.

    Malaria antigens and methods of use

    公开(公告)号:US10022432B2

    公开(公告)日:2018-07-17

    申请号:US15800975

    申请日:2017-11-01

    Applicant: GenVec, Inc.

    Abstract: The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against Plasmodium species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a Plasmodium parasite in a mammal.

    METHOD FOR PROPAGATING ADENOVIRAL VECTORS ENCODING INHIBITORY GENE PRODUCTS
    39.
    发明申请
    METHOD FOR PROPAGATING ADENOVIRAL VECTORS ENCODING INHIBITORY GENE PRODUCTS 审中-公开
    用于传播编码基因产物的腺病毒载体的方法

    公开(公告)号:US20140273228A1

    公开(公告)日:2014-09-18

    申请号:US14288493

    申请日:2014-05-28

    Applicant: GenVec, Inc.

    Abstract: The invention provides a method of propagating an adenoviral vector. The method comprises (a) providing a cell comprising a cellular genome comprising a nucleic acid sequence encoding a tetracycline operon repressor protein (tetR), and (b) contacting the cell with an adenoviral vector comprising a heterologous nucleic acid sequence encoding a toxic protein. The heterologous nucleic acid sequence is operably linked to a promoter and one or more tetracycline operon operator sequences (tetO), and expression of the heterologous nucleic acid sequence is inhibited in the presence of tetR, such that the adenoviral vector is propagated. The invention also provides a system comprising the aforementioned cell and adenoviral vector.

    Abstract translation: 本发明提供了一种繁殖腺病毒载体的方法。 该方法包括(a)提供包含细胞基因组的细胞,所述细胞基因组包含编码四环素操纵子阻遏蛋白(tetR)的核酸序列,和(b)使细胞与包含编码毒性蛋白质的异源核酸序列的腺病毒载体接触。 异源核酸序列可操作地连接到启动子和一个或多个四环素操纵子操纵子序列(tetO),并且异源核酸序列的表达在tetR存在下被抑制,使得腺病毒载体被繁殖。 本发明还提供了包含上述细胞和腺病毒载体的系统。

    METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR
    40.
    发明申请
    METHODS OF GENE THERAPY FOR TREATING DISORDERS OF THE EAR BY ADMINISTERING A VECTOR ENCODING AN ATONAL-ASSOCIATED FACTOR 审中-公开
    通过管理编码相关因子的矢量来治疗耳朵疾病的基因治疗方法

    公开(公告)号:US20140005257A1

    公开(公告)日:2014-01-02

    申请号:US14024749

    申请日:2013-09-12

    Applicant: GENVEC, INC.

    Abstract: The invention is directed to a method of changing the sensory perception of an animal. The method comprises administering an expression vector comprising a nucleic acid sequence encoding an atonal-associated factor, which is expressed to produce the atonal-associated factor resulting in generation of hair cells that allow perception of stimuli in the inner ear. Also provided is a method of generating a hair cell in differentiated sensory epithelia in vivo. The method comprises contacting differentiated sensory epithelial cells with an adenoviral vector (a) deficient in one or more replication-essential gene functions of the E1 region and E4 region, (b) comprising a spacer in the E4 region, and (c) comprising a nucleic acid sequence encoding an atonal-associated factor. The nucleic acid sequence is expressed to produce the atonal-associated factor such that a hair cell is generated. An adenoviral vector encoding an atonal-associated factor also is provided.

    Abstract translation: 本发明涉及一种改变动物的感觉知觉的方法。 所述方法包括施用包含编码无关联因子的核酸序列的表达载体,所述核酸序列被表达以产生导致产生能够感知内耳中的刺激的毛细胞的无关性因子。 还提供了一种在体内在分化感觉上皮细胞中产生毛细胞的方法。 该方法包括使分化的感觉上皮细胞与E1区和E4区的一个或多个复制必需基因功能缺陷的腺病毒载体(a)接触,(b)在E4区中包含间隔基,和(c)包含 编码无关联因子的核酸序列。 表达核酸序列以产生无创因子,从而产生毛细胞。 还提供了编码无关联因子的腺病毒载体。

Patent Agency Ranking